A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer (Q37218535)

19 August 2017

0 references

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer (English)

1 reference

19 August 2017

1 reference

Olli-Pekka Kallioniemi

series ordinal

14

1 reference

19 August 2017

15

1 reference

19 August 2017

13

Jiri Bartek

0 references

Kristiina Aittomäki

series ordinal

9

object named as

Kristiina Aittomäki

1 reference

19 August 2017

2

Jirina Bartkova

1 reference

19 August 2017

12

Carl Blomqvist

1 reference

19 August 2017

6

Outi Kilpivaara

1 reference

19 August 2017

10

Päivi Heikkilä

1 reference

19 August 2017

3

Hannaleena Eerola

1 reference

19 August 2017

7

Anitta Tamminen

1 reference

19 August 2017

1

Pia Vahteristo

1 reference

19 August 2017

4

Kirsi Syrjäkoski

1 reference

19 August 2017

11

Kaija Holli

1 reference

19 August 2017

Salla Ojala

5

1 reference

PMC publication ID

379177

19 August 2017

Juha Kononen

series ordinal

8

1 reference

PMC publication ID

379177

19 August 2017

language of work or name

English

0 references

publication date

28 July 2002

1 reference

American Journal of Human Genetics

19 August 2017

1 reference

19 August 2017

71

1 reference

19 August 2017

2

1 reference

19 August 2017

432-438

1 reference

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=379177

A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=379177

CHK2 kinase--a busy messenger.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=379177

The many substrates and functions of ATM

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=379177

A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=379177

The DNA damage response: putting checkpoints in perspective

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=379177

Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=379177

hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=379177

The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=379177

Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=379177

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=379177

A systematic review of genetic polymorphisms and breast cancer risk.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=379177

Linkage of ATM to cell cycle regulation by the Chk2 protein kinase

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=379177

Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=379177

DNA damage-activated kinase Chk2 is independent of proliferation or differentiation yet correlates with tissue biology.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=379177

Characterization of tumor-associated Chk2 mutations

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=379177

Analysis of the CHK2 gene in lymphoid malignancies

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=379177

p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=379177

Population-Based Study of BRCA1 and BRCA2 Mutations in 1035 Unselected Finnish Breast Cancer Patients

3 September 2018

1 reference

12 December 2020

Mutation analysis of the DNA-damage checkpoint gene CHK2 in myelodysplastic syndromes and acute myeloid leukemias

1 reference

12 December 2020

Familial breast cancer in southern Finland

1 reference

12 December 2020

Histological type-selective, tumor-predominant expression of a novel CHK1 isoform and infrequent in vivo somatic CHK2 mutation in small cell lung cancer

1 reference

12 December 2020

Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study

1 reference

12 December 2020

Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland)

1 reference

12 December 2020

Chk2 tumour suppressor protein in human spermatogenesis and testicular germ-cell tumours

1 reference

12 December 2020

Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome

1 reference

12 December 2020

Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors

1 reference

12 December 2020

Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes

1 reference

12 December 2020

Identifiers

DOI

10.1086/341943

1 reference

19 August 2017

1 reference

19 August 2017

1 reference

PMC publication ID

379177